These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32311760)

  • 1. Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment.
    Keil SD; Ragan I; Yonemura S; Hartson L; Dart NK; Bowen R
    Vox Sang; 2020 Aug; 115(6):495-501. PubMed ID: 32311760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment.
    Keil SD; Bowen R; Marschner S
    Transfusion; 2016 Dec; 56(12):2948-2952. PubMed ID: 27805261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light.
    Ragan I; Hartson L; Pidcoke H; Bowen R; Goodrich R
    PLoS One; 2020; 15(5):e0233947. PubMed ID: 32470046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
    Keil SD; Saakadze N; Bowen R; Newman JL; Karatela S; Gordy P; Marschner S; Roback J; Hillyer CD
    Transfusion; 2015 Apr; 55(4):858-63. PubMed ID: 25438832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment.
    Ferrari A; Cassaniti I; Sammartino JC; Mortellaro C; Del Fante C; De Vitis S; Barone E; Troletti D; Prati F; Baldanti F; Percivalle E; Cesare P
    Transfus Apher Sci; 2022 Aug; 61(4):103398. PubMed ID: 35227599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of riboflavin and ultraviolet light on the infectivity of arboviruses.
    Faddy HM; Prow NA; Fryk JJ; Hall RA; Keil SD; Goodrich RP; Marks DC
    Transfusion; 2015 Apr; 55(4):824-31. PubMed ID: 25370822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards the understanding of the UV light, riboflavin and additive solution contributions to the in vitro lesions observed in Mirasol®-treated platelets.
    Abonnenc M; Crettaz D; Sonego G; Escolar G; Tissot JD; Prudent M
    Transfus Clin Biol; 2019 Nov; 26(4):209-216. PubMed ID: 31563447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion.
    Feys HB; Van Aelst B; Devreese K; Devloo R; Coene J; Vandekerckhove P; Compernolle V
    Vox Sang; 2014 May; 106(4):307-15. PubMed ID: 24460692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of use of riboflavin and ultraviolet light for pathogen inactivation on quality of platelet concentrates].
    Stanojković Z; Antić A; Stojanović M
    Vojnosanit Pregl; 2011 Jun; 68(6):489-94. PubMed ID: 21818915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment.
    Keil SD; Bengrine A; Bowen R; Marschner S; Hovenga N; Rouse L; Gilmour D; Duverlie G; Goodrich RP
    Transfusion; 2015 Jul; 55(7):1736-44. PubMed ID: 25731607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amotosalen and ultraviolet A light efficiently inactivate MERS-coronavirus in human platelet concentrates.
    Hashem AM; Hassan AM; Tolah AM; Alsaadi MA; Abunada Q; Damanhouri GA; El-Kafrawy SA; Picard-Maureau M; Azhar EI; Hindawi SI
    Transfus Med; 2019 Dec; 29(6):434-441. PubMed ID: 31696565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a mitochondrial DNA real-time polymerase chain reaction assay for quality control of pathogen reduction with riboflavin and ultraviolet light.
    Bakkour S; Chafets DM; Wen L; van der Meer PF; Mundt JM; Marschner S; Goodrich RP; Busch MP; Lee TH
    Vox Sang; 2014 Nov; 107(4):351-9. PubMed ID: 24976130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.
    Steinmann E; Gravemann U; Friesland M; Doerrbecker J; Müller TH; Pietschmann T; Seltsam A
    Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogen reduction of monkeypox virus in plasma and whole blood using riboflavin and UV light.
    Ragan IK; Hartson LM; Sullivan EJ; Bowen RA; Goodrich RP
    PLoS One; 2023; 18(1):e0278862. PubMed ID: 36662705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of Middle East respiratory syndrome-coronavirus in human plasma using amotosalen and ultraviolet A light.
    Hindawi SI; Hashem AM; Damanhouri GA; El-Kafrawy SA; Tolah AM; Hassan AM; Azhar EI
    Transfusion; 2018 Jan; 58(1):52-59. PubMed ID: 29239484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Photochemical inactivation of pathogens in platelets and plasma: five years of clinical use in routine and hemovigilance. Towards a change of paradigm in transfusion safety].
    Cazenave JP
    Transfus Clin Biol; 2011 Apr; 18(2):53-61. PubMed ID: 21474358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light.
    Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
    Vox Sang; 2020 Apr; 115(3):146-151. PubMed ID: 31930543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riboflavin and ultraviolet light: impact on dengue virus infectivity.
    Faddy HM; Fryk JJ; Watterson D; Young PR; Modhiran N; Muller DA; Keil SD; Goodrich RP; Marks DC
    Vox Sang; 2016 Oct; 111(3):235-241. PubMed ID: 27281512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method.
    Schubert P; Culibrk B; Karwal S; Serrano K; Levin E; Bu D; Bhakta V; Sheffield WP; Goodrich RP; Devine DV
    Transfusion; 2015 Apr; 55(4):815-23. PubMed ID: 25355434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a riboflavin and ultraviolet light-based device to treat whole blood.
    Reddy HL; Doane SK; Keil SD; Marschner S; Goodrich RP
    Transfusion; 2013 Jan; 53 Suppl 1():131S-136S. PubMed ID: 23301965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.